Stocks · Health care · Surgical & Medical Instruments & Apparatus

Bioventus Inc.

BVS Clue Score54
United States Fiscal year ends December CIK 0001665988 Results filed 2 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Michelle McMurry-Heath
11 Mar 2026
Director
Sell
12,000
$8.79
$105.44K
Guy P Nohra
4 Dec 2025
Director
Sell
10,000
$7.57
$75.66K
Michelle McMurry-Heath
7 Nov 2025
Director
Sell
17,701
$7.42
$131.25K
Mark Leonard Singleton
22 Mar 2024
SVP & CFO
Sell
5,541
$5.39
$29.85K
Katrina J Church
15 Mar 2024
SVP & Chief Compliance Officer
Sell
1,217
$5.46
$6.64K
Anthony D'Adamio
15 Mar 2024
SVP & General Counsel
Sell
3,125
$5.46
$17.06K
Katrina J Church
3 Jul 2023
SVP & Chief Compliance Officer
Sell
394
$2.83
$1.12K
Mark Leonard Singleton
24 Mar 2023
SVP & CFO
Sell
6,044
$1.27
$7.68K
Katrina J Church
15 Mar 2023
SVP & Chief Compliance Officer
Sell
1,332
$1.39
$1.85K
Kenneth Michael Reali
15 Mar 2023
Chief Executive Officer
Sell
9,811
$1.39
$13.62K
Anthony D'Adamio
15 Mar 2023
SVP & General Counsel
Sell
3,409
$1.39
$4.74K
Alessandra Pavesio
4 Apr 2022
SVP & Chief Science Officer
Sell
32,997
$11.17
$368.42K
John Nosenzo
4 Apr 2022
Chief Commercial Officer
Sell
65,963
$11.12
$733.50K
Anthony D'Adamio
4 Apr 2022
SVP & General Counsel
Sell
16,016
$11.19
$179.24K
John Nosenzo
14 Feb 2022
Chief Commercial Officer
Sell
534
$11.99
$6.40K
Gregory O. Anglum
14 Feb 2022
SVP & CFO
Sell
1,294
$11.99
$15.52K
Anthony D'Adamio
14 Feb 2022
SVP & General Counsel
Sell
1,294
$11.99
$15.51K
Alessandra Pavesio
14 Feb 2022
SVP & Chief Science Officer
Sell
433
$11.99
$5.19K

What was left out

Form 4 filings counted 218
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 29
Sales straight out of an exercise 0
Sales at will 18
Transactions with no price 0
Shares from compensation/vesting 5,582,044
Sales filed before the plan box existed 10
History held since 16 Feb 2021